STEM Share Price

Open 1.26 Change Price %
High 1.48 1 Day 0.05 4.07
Low 1.15 1 Week 0.05 4.07
Close 1.28 1 Month 0.50 64.10
Volume 2834478 1 Year 0.76 146.15
52 Week High 3.90
52 Week Low 0.00
STEM Important Levels
Resistance 2 1.59
Resistance 1 1.46
Pivot 1.30
Support 1 1.10
Support 2 0.97
NASDAQ USA Most Active Stocks
SIRI 4.30 -5.49%
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
QQQ 115.67 0.17%
WRES 0.09 0.00%
More..
NASDAQ USA Top Gainers Stocks
QKLS 0.21 110.00%
LOCM 0.09 50.00%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
PERF 1.90 22.58%
ASNA 7.01 20.24%
SBSA 4.60 17.95%
CEMP 7.55 15.27%
XXIA 15.55 14.76%
More..
NASDAQ USA Top Losers Stocks
PTIX 0.00 -100.00%
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
AMCF 0.03 -50.00%
OPXAW 0.01 -50.00%
VALV 0.03 -50.00%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
More..

StemCells, Inc. (NASDAQ: STEM)

STEM Technical Analysis 3
As on 28th Nov 2016 STEM Share Price closed @ 1.28 and we RECOMMEND Buy for LONG-TERM with Stoploss of 0.80 & Buy for SHORT-TERM with Stoploss of 1.13 we also expect STOCK to react on Following IMPORTANT LEVELS.
STEM Target for December
1st Target up-side 1.82
2nd Target up-side 2.2
3rd Target up-side 2.58
1st Target down-side 0.74
2nd Target down-side 0.36
3rd Target down-side -0.02
STEM Other Details
Segment EQ
Market Capital 60820800.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.stemcellsinc.com
STEM Address
STEM
7707 Gateway Boulevard
Suite 140
Newark, CA 94560
United States
Phone: 510-456-4000
Fax: 510-456-4001
Interactive Technical Analysis Chart StemCells, Inc. ( STEM NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on StemCells, Inc.
STEM Business Profile
StemCells, Inc. (StemCells) is engaged in the research, development, and commercialization of stem cell therapeutics and related tools and technologies for academia and industry. The Company is focused on developing and commercializing stem and progenitor cells as the basis for therapeutics and therapies, and cells and related tools and technologies to enable stem cell-based research and drug discovery and development. The Company�s primary research and development efforts are focused on identifying and developing stem and progenitor cells as potential therapeutic agents. The Company has two therapeutic product development programs, including its CNS Program, which is developing applications for HuCNS-SC cells, its human neural stem cell product candidate, and its Liver Program, which is characterizing the Company�s human liver cells as a therapeutic product.